Skip to content

Net margin at other companies

McKesson logo
McKessonMCK
1.2%+0.3pp
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-26.3%-33.2pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
3.6%-0.5pp
Summit Therapeutics logo
Summit TherapeuticsSMMT
-271,685%-275,966pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
2.3%

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Calculated from The Oncology Institute, Inc.’s reported figures.

Based on trailing twelve months.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s net margin?
The Oncology Institute, Inc. (TOI) reported net margin of -8% in Q1 2026.
How has The Oncology Institute, Inc.'s net margin changed year-over-year?
The Oncology Institute, Inc.'s net margin increased by 50.1% year-over-year, from -16% to -8%.
What is the long-term trend for The Oncology Institute, Inc.'s net margin?
Over 4 years (2020 to 2025), The Oncology Institute, Inc.'s net margin has grown at a 12.1% compound annual growth rate (CAGR), from -7.6% to -12.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.